Retraction to: Liver Kinase B1 Is Required for White Adipose Tissue Growth and Differentiation (Diabetes 2013;62:2347–2358 (10.2337/db12-1229));Liver kinase b1 is required for white adipose tissue growth and differentiation

Diabetes

Volumn 62, Issue 7, 2013, Pages 2347-2358

  Zhang, Wencheng ^a   Wang, Qilong ^a   Song, Ping ^a   Zou, Ming Hui ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN RECEPTOR SUBSTRATE 1; LIVER KINASE B1; PEROXISOME PROLIFERATOR; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; ADENYLATE KINASE; INSULIN RECEPTOR SUBSTRATE; IRS1 PROTEIN, MOUSE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN SERINE THREONINE KINASE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STK11 PROTEIN, MOUSE;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DEATH; HORMONE RELEASE; LOXP SITE; MOUSE; NONHUMAN; POSTNATAL GROWTH; PRIORITY JOURNAL; WEANING; WHITE ADIPOSE TISSUE; ANIMAL; CYTOLOGY; GENETICS; KNOCKOUT MOUSE; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

ADENYLATE KINASE; ADIPOCYTES; ADIPOGENESIS; ADIPOSE TISSUE, WHITE; ANIMALS; INSULIN RECEPTOR SUBSTRATE PROTEINS; MICE; MICE, KNOCKOUT; PHOSPHORYLATION; PPAR GAMMA; PROTEIN-SERINE-THREONINE KINASES; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

EID: 84883692803     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db23-rt07b     Document Type: Erratum

References (45)

1. Koutnikova H, Cock TA, Watanabe M, et al. Compensation by the muscle limits the metabolic consequences of lipodystrophy in PPAR gamma hypomorphic mice. Proc Natl Acad Sci USA 2003;100:14457-14462
2. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 2000;11:327-332
3. Farmer SR. Transcriptional control of adipocyte formation. Cell Metab 2006;4:263-273
4. Linhart HG, Ishimura-Oka K, DeMayo F, et al. C/EBPalpha is required for differentiation of white, but not brown, adipose tissue. Proc Natl Acad Sci USA 2001;98:12532-12537
5. Rosen ED, MacDougald OA. Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 2006;7:885-896
6. Tseng YH, Kriauciunas KM, Kokkotou E, Kahn CR. Differential roles of insulin receptor substrates in brown adipocyte differentiation. Mol Cell Biol 2004;24:1918-1929
7. Laustsen PG, Michael MD, Crute BE, et al. Lipoatrophic diabetes in Irs1 (-/-)/Irs3(-/-) double knockout mice. Genes Dev 2002;16:3213-3222
8. Murata Y, Tsuruzoe K, Kawashima J, et al. IRS-1 transgenic mice show increased epididymal fat mass and insulin resistance. Biochem Biophys Res Commun 2007;364:301-307
9. DeMambro VE, Kawai M, Clemens TL, et al. A novel spontaneous mutation of Irs1 in mice results in hyperinsulinemia, reduced growth, low bone mass and impaired adipogenesis. J Endocrinol 2010;204:241-253
10. Peng XD, Xu PZ, Chen ML, et al. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev 2003;17:1352-1365
11. Lee AV, Gooch JL, Oesterreich S, Guler RL, Yee D. Insulin-like growth factor I-induced degradation of insulin receptor substrate 1 is mediated by the 26S proteasome and blocked by phosphatidylinositol 39-kinase inhibition. Mol Cell Biol 2000;20:1489-1496
12. Pederson TM, Kramer DL, Rondinone CM. Serine/threonine phosphorylation of IRS-1 triggers its degradation: possible regulation by tyrosine phosphorylation. Diabetes 2001;50:24-31
13. Sun XJ, Goldberg JL, Qiao LY, Mitchell JJ. Insulin-induced insulin receptor substrate-1 degradation is mediated by the proteasome degradation pathway. Diabetes 1999;48:1359-1364
14. Xu X, Sarikas A, Dias-Santagata DC, et al. The CUL7 E3 ubiquitin ligase targets insulin receptor substrate 1 for ubiquitin-dependent degradation. Mol Cell 2008;30:403-414
15. Giardiello FM, Trimbath JD. Peutz-Jeghers syndrome and management recommendations. Clin Gastroenterol Hepatol 2006;4:408-415
16. Katajisto P, Vallenius T, Vaahtomeri K, et al. The LKB1 tumor suppressor kinase in human disease. Biochim Biophys Acta 2007;1775:63-75
17. Alessi DR, Sakamoto K, Bayascas Jr. LKB1-dependent signaling pathways. Annu Rev Biochem 2006;75:137-163
18. Shackelford DB, Shaw RJ. The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer 2009;9:563-575
19. Sakamoto K, McCarthy A, Smith D, et al. Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction.EMBO J 2005;24:1810-1820
20. Fu A, Ng AC, Depatie C, et al. Loss of Lkb1 in adult beta cells increases beta cell mass and enhances glucose tolerance in mice. Cell Metab 2009;10: 285-295
21. Ylikorkala A, Rossi DJ, Korsisaari N, et al. Vascular abnormalities and deregulation of VEGF in Lkb1-deficient mice. Science 2001;293:1323-1326
22. Bardeesy N, Sinha M, Hezel AF, et al. Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation. Nature 2002;419:162-167
23. Wang P, Mariman E, Renes J, Keijer J. The secretory function of adipocytes in the physiology of white adipose tissue. J Cell Physiol 2008;216:3-13
24. Kovacs WJ, Shackelford JE, Tape KN, et al. Disturbed cholesterol homeostasis in a peroxisome-deficient PEX2 knockout mouse model. Mol Cell Biol 2004;24:1-13
25. Kovanen PT, Nikkilä EA, Miettinen TA. Regulation of cholesterol synthesis and storage in fat cells. J Lipid Res 1975;16:211-223
26. Esposito DL, Li Y, Cama A, Quon MJ. Tyr(612) and Tyr(632) in human insulin receptor substrate-1 are important for full activation of insulinstimulated phosphatidylinositol 3- kinase activity and translocation of GLUT4 in adipose cells. Endocrinology 2001;142:2833-2840
27. Sun XJ, Crimmins DL, Myers MG Jr, Miralpeix M, White MF. Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1. Mol Cell Biol 1993;13:7418-7428
28. Tzatsos A, Kandror KV. Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation. Mol Cell Biol 2006;26:63-76
29. Li Y, Xu S, Mihaylova MM, et al. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab 2011;13:376-388
30. Asterholm IW, Halberg N, Scherer PE. Mouse Models of Lipodystrophy Key reagents for the understanding of the metabolic syndrome. Drug Discov Today Dis Models 2007;4:17-24
31. Luo J, Sladek R, Carrier J, Bader JA, Richard D, Giguère V. Reduced fat mass in mice lacking orphan nuclear receptor estrogen-related receptor alpha. Mol Cell Biol 2003;23:7947-7956
32. Wang ND, Finegold MJ, Bradley A, et al. Impaired energy homeostasis in C/EBP alpha knockout mice. Science 1995;269:1108-1112
33. Xiao C, Kim HS, Lahusen T, et al. SIRT6 deficiency results in severe hypoglycemia by enhancing both basal and insulin-stimulated glucose uptake in mice. J Biol Chem 2010;285:36776-36784
34. Yokoyama C, Wang X, Briggs MR, et al. SREBP-1, a basic-helix-loophelix- leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell 1993;75:187-197
35. Shimomura I, Shimano H, Horton JD, Goldstein JL, Brown MS. Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells. J Clin Invest 1997;99:838-845
36. Shimano H, Horton JD, Shimomura I, Hammer RE, Brown MS, Goldstein JL. Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. J Clin Invest 1997;99:846-854
37. Shimano H, Yahagi N, Amemiya-Kudo M, et al. Sterol regulatory elementbinding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes. J Biol Chem 1999;274:35832-35839
38. Shimomura I, Hammer RE, Richardson JA, et al. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev 1998;12:3182-3194
39. Habinowski SA, Witters LA. The effects of AICAR on adipocyte differentiation of 3T3- L1 cells. Biochem Biophys Res Commun 2001;286:852-856
40. Lee H, Kang R, Bae S, Yoon Y. AICAR, an activator of AMPK, inhibits adipogenesis via the WNT/b-catenin pathway in 3T3-L1 adipocytes. Int J Mol Med 2011;28:65-71
41. Bauwens JD, Schmuck EG, Lindholm CR, et al. Cold tolerance, cold-induced hyperphagia, and nonshivering thermogenesis are normal in α1-AMPK-/- mice. Am J Physiol Regul Integr Comp Physiol 2011;301:R473-R483
42. Vila-Bedmar R, Lorenzo M, Fernández-Veledo S. Adenosine 59- monophosphateactivated protein kinase-mammalian target of rapamycin cross talk regulates brown adipocyte differentiation. Endocrinology 2010;151:980-992
43. Baker J, Liu JP, Robertson EJ, Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 1993;75:73-82
44. Wang Y, Nishida S, Sakata T, et al. Insulin-like growth factor-I is essential for embryonic bone development. Endocrinology 2006;147:4753-4761
45. Hauner H, Entenmann G, Wabitsch M, et al. Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium. J Clin Invest 1989;84:1663-1670